Clinical trialNCT04365101TerminatedPhase 1/PHASE2Interventional

Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19

SponsorCelularity IncorporatedEnrollment7ARDSAnalgesicsAnti-infective AgentsAntimetabolites, AntineoplasticAntiviral AgentsCoronaviridae Infections+14 more conditions

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study is a Phase 1 / 2 trial to determine the safety and efficacy of CYNK-001, an immunotherapy containing Natural Killer (NK) cells derived from human placental CD34+ cells and culture-expanded, in patients with moderate COVID-19 disease.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Corey Casper, MD MPH
Access to Advanced Health Institute (AAHI)
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Uc Irvine
Irvine, California, United States
Atlantic Health
Morristown, New Jersey, United States
Atlantic Health
Summit, New Jersey, United States
Multicare Health System
Tacoma, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

CYNK-001

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 2 Sept 2020
Primary completion: 30 Aug 2021
Completion: 15 Feb 2023
Last update posted: 26 Jun 2026
Registered enrollment: 7
Registry id: NCT04365101

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.